Role of bradykinin in the reduction of left ventricular hypertrophy induced by angiotensin-converting enzyme inhibitors in spontaneously hypertensive rats

Japanese Journal of Pharmacology

Volumn 76, Issue 4, 1998, Pages 431-434

  Sugimoto, Koh Ichi ^a   Fujimura, Akio ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Angiotensin converting enzyme inhibitor; Bradykinin; Left ventricular hypertrophy

Indexed keywords

BRADYKININ; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ICATIBANT; IMIDAPRIL; RAMIPRIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; HEART LEFT VENTRICLE HYPERTROPHY; HYPERTENSION; INTRAGASTRIC DRUG ADMINISTRATION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031958949     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.76.431     Document Type: Article

References (10)

1. Dahlöf B, Pennert K and Hansson L: Reversal of left ventricular hypertrophy in hypertensive patients: a meta-analysis of 109 treatment studies. Am J Hypertens 5, 95-110 (1992)
2. 2 bradykinin receptor antagonist HOE 140 abolishes the antihypertrophic effect of ramipril. Br J Pharmacol 105, 771-772 (1992)
3. Sasaguri T, Ideishi M, Kinoshita A and Arakawa K: Differential inhibition of bradykinin hydrolysis by four ACE inhibitors: a possible explanation for differences in induced coughing. Hypertens Res 17, 253-258 (1994)
4. Bao G, Gohlke P, Qadri F and Unger T: Chronic kinin receptor blockade attenuates the antihypertensive effect of ramipril. Hypertension 20, 74-79 (1992)
5. Bao G, Gohlke P and Unger T: Role of bradykinin in chronic antihypertensive actions of ramipril in different hypertensive models. J Cardiovasc Pharmacol 20, Suppl 9, S96-S99 (1992)
6. Gohlke P, Linz W, Schölkens BA, Kuwer I, Bartenbach S, Schnell A and Unger T: Angiotensin-converting enzyme inhibition improves cardiac function: role of bradykinin. Hypertension 23, 411-418 (1994)
7. Jaspard E, Wei L and Alhenc-Gelas F: Differences in the properties and enzymatic specificities of the two active sites of angiotensin I-converting enzyme (kininase II). Studies with bradykinin and other natural peptides. J Biol Chem 268, 9496-9503 (1993)
8. Drummer OH, Kourtis S and Johnson H: Effect of chronic enalapril treatment on enzymes responsible for the catabolism of angiotensin I and formation of angiotensin II. Biochem Pharmacol 39, 513-518 (1990)
9. Hooper NM, Hryszko J, Oppong SY and Turner AJ: Inhibition by converting enzyme inhibitors of pig kidney aminopeptidase P. Hypertension 19, 281-285 (1992)
10. Gohlke P, Bunning P, Bönner G and Unger T: ACE inhibitor effect on bradykinin metabolism in the vascular wall: agents and actions. In Recent Progress on Kinins, Edited by Bönner G, Fritz H, Schölkens BA, Dietze G and Luppetz K, pp 178-185, Birkhauser Verlag, Berlin (1992)